What is Legionnaires' disease? The symptoms of the potentially deadly disease to watch for
The serious form of pneumonia is caused by Legionella bacteria and approximately one in 10 people who are sickened will die due to complications.
So, what symptoms should people look out for and how is Legionnaires' disease transmitted? Here's what to know.
What is Legionnaires' disease?
Legionnaires' disease is a severe form of pneumonia – or lung inflammation usually caused by a bacterial, viral or fungal infection. In the recent New York City outbreak, the disease is caused by Legionella bacteria. The disease is transmitted by inhaling the bacteria from water or soil.
What are the causes of this disease?
Legionella bacteria is responsible for most cases of Legionnaires' disease. The bacterium is often found outdoors but the Mayo Clinic says it rarely causes infections there.
It is also possible to get the disease from home plumbing, with most outbreaks occurring in large buildings, 'perhaps because complex systems allow the bacteria to grow and spread more easily,' the clinic noted.
Previous outbreaks have been linked to:
• Hot tubs and whirlpools
• Cooling towers in air conditioning systems
• Hot water tanks and heaters
• Decorative fountains
• Swimming pools
• Birthing pools
• Drinking water
The infection can also be transmitted through aspiration, which occurs when liquids accidentally enter your lungs, and through soil.
What are the symptoms?
Legionnaires' disease usually develops between two to 14 days after exposure to legionella bacteria, according to the Centers for Disease Control and Prevention.
Some of the symptoms include:
• Headache
• Muscle aches
• A fever
By the second or third day, you may develop other signs and symptoms such as:
• A cough that might bring up mucus and sometimes blood. As many as 50% of patients can have phlegm as well.
• Shortness of breath
• Chest pain
• Confusion
• Nausea and or vomiting
• Diarrhea
'Although Legionnaires' disease primarily affects the lungs, it occasionally can cause infections in wounds and in other parts of the body, including the heart,' the Mayo Clinic said. Possible complications include lung failure and death.
There is also a mild form of Legionnaires' disease known as Pontiac fever which can produce a fever, chills and muscle aches. This fever does not affect the lungs and usually clears up within two to five days.
Who is most at risk?
In most cases, not everyone exposed to the bacteria becomes sick. But, exposure means some people are at a higher risk of infection.
Those people include smokers. People with weakened immune systems, those with chronic lung diseases or other chronic conditions, and people over 50 are also at greater risk.
Is the disease contagious?
The disease is not contagious and you cannot get it from another person, according to the Cleveland Clinic.
How is it diagnosed?
A simple x-ray of a person's chest can tell if someone has pneumonia, but other tests are necessary to see if Legionella is responsible.
Those include a urine or lab test that takes fluid from the lung or phlegm.
How is the disease treated?
There is no vaccine for Legionnaires' disease. If diagnosed with the disease, you may need to go to the hospital. Medical staff may be able to give patients antibiotics or administer oxygen through a face mask or a breathing machine.
When you are showing signs of recovery, the doctor might prescribe antibiotic medication that usually lasts for between one and three weeks.
'Any pneumonia can cause a lingering type of fatigue,' Dr. Ben Singer, a pulmonary and critical care specialist at Northwestern Medicine, told The New York Times. 'People can take a long time to get better.'
How can you avoid infection?
The key lies in prevention. People should clean any water-using devices and flush faucets, according to the Centers for Disease Control and Prevention.
Buildings and devices at an increased risk for growth should have a water management program, the agency said.
The bacteria can also grow in vehicles' windshield wiper fluid tanks.
'To prevent growth and spread of Legionella, only use genuine windshield cleaner fluid and follow the vehicle manufacturer recommendations, if available,' the agency advised.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
43 minutes ago
- Medscape
Can Colistin-Meropenem Synergy Combat Resistant Infections?
TOPLINE: Synergistic therapy combining colistin and meropenem reduced clinical failure rates in carbapenem-resistant infections and was particularly effective in Acinetobacter baumannii pneumonia cases. METHODOLOGY: Researchers reported the findings from a secondary analysis of a randomized, double-blind trial that assessed the impact of synergistic therapy of colistin and meropenem on carbapenem-resistant pneumonia and/or bloodstream in adults. Overall, 407 patients (mean age, 68.0 years; 50.9% White; 63.5% men) were categorized into receiving synergistic combination therapy (n = 146) and functional monotherapy (n = 261) that included non-synergistic combination therapy and monotherapy. Outcomes of interest were 28-day all-cause mortality, clinical failure, and microbiologic cure. Clinical failure was defined as death during or within 7 days of treatment; rescue therapy initiation within 7 days of treatment; treatment discontinuation due to adverse events; persistent bacteremia > 5 days of treatment; or no improvement or worsening of oxygenation at treatment end in those with pneumonia. TAKEAWAY: The most common pathogen was carbapenem-resistant A baumannii (n = 320) patients, followed by carbapenem-resistant Enterobacterales (n = 64) and carbapenem-resistant Pseudomonas aeruginosa (n = 41). Mortality rates did not differ significantly between the synergistic combination therapy and functional monotherapy groups (38.4% vs 41.4%); however, in the bloodstream infection subgroup, a trend toward reduced mortality was observed (adjusted odds ratio [aOR], 0.42; P = .054). In the pneumonia subgroup, synergistic combination therapy demonstrated significantly reduced clinical failure rates (62.6% vs 71.8%; aOR, 0.54; P = .04), and a similar but nonsignificant trend was observed in A baumannii infections (57.4% vs 69.4%; aOR, 0.60; P = .06). Microbiologic cure rates were similar between the study groups, with similar outcomes observed across subgroups defined by infection type and pathogen type. IN PRACTICE: "As synergism between colistin and meropenem is frequently present in A baumannii, when treating severe A baumannii infection with polymyxin-based therapy, consideration might be given to combination therapy with meropenem," the authors wrote. SOURCE: The study was led by Mariya Huralska, MD, from Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, and Jason M. Pogue, PharmD, from the University of Michigan College of Pharmacy in Ann Arbor. It was published online on July 19, 2025, in Clinical Infectious Diseases. LIMITATIONS: The main limitation was that more than three quarters of the study pathogens were A baumannii, which limited the power to determine associations between synergy and outcomes for carbapenem-resistant Enterobacterales and P aeruginosa. Additionally, the findings might be applicable to polymyxin B; however, definitive conclusions cannot not be drawn as colistin was used in the trial. DISCLOSURES: The study was supported by the National Institute of Allergy and Infectious Diseases. Some authors disclosed serving in consulting, advisory, or other financial support roles for Merck, Shionogi, Melinta, Entasis, GlaxoSmithKline, or VenatoRx. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Newsweek
44 minutes ago
- Newsweek
Map Shows States With Highest Rates of Death by Heart Disease
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Data published by the Centers for Disease Control and Prevention (CDC) has revealed the states with the highest rates of deaths caused by heart disease. In Newsweek's visualization, below, one can see in dark red that the states of Alabama, Mississippi and Oklahoma came top of the list with incidence rates, respectively, of around 234, 248, and 257 deaths per 100,000 total population. Shown in orange, the states of Arkansas, Kentucky, Louisiana, Michigan, Missouri, Nevada, Ohio, Tennessee and West Virginia, followed closely with rate between 191.5 to 229.8 per 100,000 people. The states with the lowest death rate caused by heart disease include Minnesota, Hawaii, Alaska, Florida, Colorado and New Jersey, among others. What Is Heart Disease? As the CDC explains, "heart disease" is an umbrella term that includes several types of heart conditions, with the most common one in America being coronary artery disease. This condition reduces blood flow to the heart, which in turn reduces circulation, leading to a heart attack if left untreated. In some cases, heart disease doesn't show any warning signs until something serious happens, including heart attacks, arrhythmia and heart failure. A heart attack may cause chest discomfort, pain in the neck or upper back, nausea, dizziness, shortness of breath or extreme tiredness. Irregular heart rhythms, called arrhythmias, might feel like fluttering or racing in the chest. Heart failure can cause breathing difficulty, tiredness, and swelling in the legs, ankles, stomach, and neck veins. Who Is at Risk of Heart Disease? The three key risk factors for heart disease include high blood pressure, high blood cholesterol, and smoking. According to the CDC almost half of Americans have at least one of these three risk factors. Other medical conditions and lifestyle choices that can also increase the risk of heart disease include, having diabetes, being overweight or obese, having an unhealthy diet, being physically inactive and drinking too much alcohol. How To Prevent Heart Disease? To prevent heart disease, healthy lifestyle choices are crucial. These may include balanced eating, regular exercise, and avoiding harmful habits, like smoking or drinking alcohol. Meals that are rich in fruits, vegetables and fiber, should be preferred over those with saturated fats, trans fats, salt and sugar. Maintaining a healthy weight is also very important, as obesity increases strain on the heart and blood vessels. Regular physical activity also helps. Adults should aim for two and half hours of moderate exercise weekly, while children need one hour daily. It is also important to manage pre-existing conditions like high blood pressure, cholesterol, and diabetes through regular check-ups, lifestyle changes and prescribed medications. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about heart disease? Let us know via science@


CBS News
44 minutes ago
- CBS News
1st homeless shelter for transgender people opening in NYC
New York City is opening the nation's first city-funded homeless shelter specifically for transgender and gender-nonconforming people. Ace's Place, a shelter with 150 beds in Long Island City, Queens, will offer transitional housing and specialized support services to members of the LGBTQ+ community, the NYC Department of Social Services says. The city is partnering with Destination Tomorrow, a national LGBTQ+ organization with centers in New York, Atlanta and Washington, D.C., to offer shelter residents resources from counseling and employment assistance to independent living, life skills and financial literacy workshops, and a culinary arts program. The shelter will have a full-time psychiatric nurse practitioner and other staff providing specialized mental health support, according to the city. Destination Tomorrow will offer yoga and meditation through its wellness programs, the city added. "We couldn't be prouder to make this historic announcement that strongly affirms our values and commitment to strengthening the safety net for transgender New Yorkers at a time when their rights are roundly under attack," Molly Wasow Park, the city's social services commissioner, said. "Ace's Place will offer Transgender New Yorkers a safe place to heal and stabilize in trauma-informed settings with the support of staff who are deeply invested in their growth and wellbeing." "The opening of the country's first city-funded TGNC shelter is more than historic — it is lifesaving," Chanel Lopez, the deputy director of LGBTQ+ affairs for the New York State Executive Chamber, said. "For far too long, my community has been pushed to the margins, forced to navigate systems that were never built with our safety or dignity in mind. This shelter represents what's possible when we center community voices, invest in affirming care, and lead with equity. Destination Tomorrow is setting not only a local, but a national standard — and I am proud to witness this moment." The New York City Department of Homeless Services is one of the largest government organizations tasked with preventing homelessness, with an operating budget of over $2 billion.